Doctor profile · Federal record
Dr. Charles Rudin, M.D., PH.D.
Hematology & Oncology Physician (CMS: Medical Oncology) · New York, NY
- NPI 1467483404
- Accepts Medicare
- MIPS 84.6 / 100 · 2023
- 33 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1275 York Ave
New York, NY 100656007
(646) 888-4336
fax (646) 888-4676 - Mailing address
-
633 3Rd Ave
New York, NY 100176706
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- April 7, 2015
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Maryland #D61040
- Medicaid
- MD #403573900
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1467483404. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
376
Distinct HCPCS
3
Medicare allowed
$59,964
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 336 | 111 | $159 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 23 | 23 | $203 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 17 | 15 | $108 |
In context: peer comparison
Among 103 peers in this city , average services per provider: 411. This provider delivers 0.9× the peer median.Open Payments
Industry payments received
All-time total
$14,664
Transactions
15
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Daiichi Sankyo Inc. | 6 | $4,232.51 | |
| AstraZeneca Pharmaceuticals LP | 3 | $2,902.52 | |
| AstraZeneca UK Limited | 1 | $2,740.00 | |
| Merck Sharp & Dohme LLC | 1 | $1,525.00 | |
| F. Hoffmann-La Roche AG | 2 | $1,520.00 | |
| Boehringer Ingelheim International GmbH | 1 | $1,058.09 | |
| Amgen Inc. | 1 | $686.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
307
Patients
70
Total drug cost
$1,321,543
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tagrisso (Osimertinib Mesylate) | Brand | 63 | 11 | $1,070,899 |
| Ondansetron Hcl | Generic | 57 | 27 | $334 |
| Dexamethasone | Generic | 48 | 21 | $307 |
| Prednisone | Generic | 25 | 11 | $157 |
| Folic Acid | Generic | 20 | 0 | $29 |
| Oxycodone Hcl | Generic | 18 | 0 | $239 |
| Xarelto (Rivaroxaban) | Brand | 18 | 0 | $10,470 |
| Eliquis (Apixaban) | Brand | 16 | 0 | $15,268 |
| Atorvastatin Calcium | Generic | 15 | 0 | $122 |
| Fentanyl | Generic | 14 | 0 | $905 |
Frequently asked questions
What is Dr. Charles Rudin's medical specialty?
Dr. Charles Rudin practices Hematology & Oncology Physician in New York, NY.
Where does Dr. Charles Rudin practice?
Dr. Charles Rudin practices at 1275 York Ave, New York, NY 100656007. Office phone: 6468884336.
What is Dr. Charles Rudin's NPI?
Dr. Charles Rudin's National Provider Identifier (NPI) is 1467483404, issued by NPPES.
Does Dr. Charles Rudin accept Medicare assignment?
Yes. Dr. Charles Rudin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Charles Rudin commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); New patient office or other outpatient visit (HCPCS 99205); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.